Alnylam Pharmaceuticals (NASDAQ:ALNY) Posts Quarterly Earnings Results, Beats Estimates By $0.23 EPS
The Cerbat Gem -

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) released its earnings results on Thursday. The biopharmaceutical company reported ($0.52) earnings per share for the quarter, beating the consensus estimate of ($0.75) by $0.23, Briefing.com reports. The firm had revenue of $494.33 million during the quarter, compared to the consensus estimate of $428.01 million. During the same […]

In related news